tirzepatide compound going away versions of GLP-1 drugs for weight loss halted by FDA Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Louisiana patients can complete the evaluation and receive ongoing provider oversight through telehealth, with in-person care remaining optional

The study shows that semaglutide has significantly greater efficacy for weight loss than liraglutide when added to a healthy lifestyle and increased physical activity

Impairment of glutathione function in the brain is linked to loss of neurons during aging and to neurological diseases including Parkinson's disease and Alzheimer's disease

The average patient age was 49.8 years with a majority of female adults (73.4%)

Monitor oxidative stress to determine the extent of cell damage using a colorimetric gluthathione assay

This shift from weekly injections to daily pills is expected to dramatically expand the patient population using GLP-1 therapy